RedCarpetLife
1545
In the world today
Jian Jun

Jian Jun

J. Jun
-0.14% | - $-3.69M
$2.68 B ₹ 24,366 Cr
Real Time Net Worth #1545 Ranking as of 21 Feb 2026 By Forbes

More on Jian Jun

Gender

Male

Age

63Y

Country

China

Born On

January, 1963

Deceased

No

Relationship Status

Married

Children

Unknown

Education

Unknown

Designation Info :

Self-Made

Yes

Entrepreneur Type

Self-Made (Medical Aesthetics)

Primary Organization

Imeik Technology Development

Titles

Chairman

Sources of Wealth

Imeik Technology

Industry

Healthcare, Pharmaceuticals, Cosmetics

About Jian Jun


J ian Jun is a Chinese entrepreneur whose wealth is derived from his family's controlling stake in the pharmaceutical company, Imeik Technology Development. The company is a leader in the rapidly growing and highly lucrative medical aesthetics market in China. Imeik specializes in producing injectable cosmetic treatments, often compared to Botox or dermal fillers.

As the chairman of the company, Jian Jun has built Imeik into a dominant domestic player, capitalizing on the immense and growing demand for non-invasive cosmetic procedures from Chinese consumers. The company is publicly traded on the Shenzhen Stock Exchange, and its soaring valuation has turned him and his family into one of the wealthiest in China's healthcare sector. His success is a story of a company that has perfectly timed its entry into a booming consumer market.

Advertisement

Quick Reads


  • Chairman of the medical aesthetics company Imeik Technology.
  • The company is a leading Chinese producer of injectable cosmetic products.
  • His fortune has soared with the booming demand for cosmetic treatments in China.
  • He and his family control the publicly listed company.
  • A major player in China's lucrative beauty economy.

Early Life and Background


Jian Jun is a Chinese businesswoman, the self-made billionaire Chairwoman of Imeik Technology Development (SZSE: 300896), a major biomedical supplier specializing in aesthetic medicine products (e.g., skin fillers and facial implant threads). Her wealth is rooted in the high-growth beauty and medical technology sector.

Jian holds an MBA from Tsinghua University. Her career began with high-level corporate roles, including working for the state-owned China National Cereals Oils and Foodstuffs Import and Export early in her career. She gained crucial international exposure working abroad (in a U.S. trade company and a textile firm in Panama), where she became interested in injection treatments (beauty lunch procedures).

  • Imeik Technology Development (Chairwoman): The core publicly traded asset, a major supplier of biomedical and aesthetic medicine products (e.g., skin fillers and facial implant threads).
  • Aesthetic Medicine Focus: Her success is built on providing innovative anti-aging and facial implant products for the booming Chinese consumer beauty market.
  • Investment Strategy: Her philosophy is rooted in scientific scale, quality control, and capitalizing on the immense demand for non-surgical cosmetic procedures (the beauty lunch).
  • Academic Background: She holds an MBA from Tsinghua University.

Career Journey of Jian Jun


Jian Jun's strategic genius was her decision to focus on the high-margin, specialized aesthetic medicine market. She returned to China in 2004 and joined Imeik as a director, gradually becoming its biggest owner and Chairwoman in 2016. Her company became famous for its Hearty filler that treats neck wrinkles.

Under her leadership, Imeik successfully executed its IPO on the Shenzhen Stock Exchange in 2020, raising more than $530 million. Her wealth is secured by the colossal, long-term, stable profitability of the aesthetic medicine sector, with the company's shares surging by more than 500 percent after listing (early 2021). Her structural contribution is tied to the successful industrialization and professionalization of cosmetic treatments in China.

Advertisement

Jian Jun's Timeline


1980s (approx.):

Works for the state-owned China National Cereals Oils and Foodstuffs Import and Export (Early Career).

2004:

Moves back to China; joins Imeik as a director (Corporate Entry).

2016:

Becomes Chairwoman of Imeik (Executive Ascent).

2020 (September):

Imeik executes its successful IPO on the Shenzhen Stock Exchange (Financial Milestone).

2021 (Early):

Shares surge more than 500 percent (Financial Apex).

Ongoing:

Continues as Chairwoman, guiding the aesthetic medicine giant (Executive Oversight).

Major Business Ventures and Investments


Jian Jun's wealth is concentrated in her controlling stake and executive leadership of the publicly traded medical technology giant, Imeik Technology Development (SZSE: 300896).

  • Imeik Technology Development (Chairwoman): The core publicly traded asset, a major supplier of biomedical and aesthetic medicine products (e.g., skin fillers and facial implant threads).
  • Aesthetic Medicine Focus: Her success is built on providing innovative anti-aging and facial implant products for the booming Chinese consumer beauty market.
  • Investment Strategy: His philosophy is rooted in scientific scale, quality control, and capitalizing on the immense demand for non-surgical cosmetic procedures (the beauty lunch).
  • Academic Background: She holds an MBA from Tsinghua University.

Advertisement

Philanthropy and Social Impact


Jian Jun's social impact is structural, stemming from Imeik's role in providing high-quality, regulated aesthetic medicine products to the Chinese consumer market, contributing to the nation's rising consumer wealth and service sector. Her structural contribution is tied to the successful industrialization of non-surgical cosmetic procedures (the beauty lunch phenomenon).

Her personal philanthropy supports various community and educational initiatives. Her career is a testament to the profitability of disciplined scientific scale and strategic branding in the high-margin beauty and medical sector.

Fashion, Style, and Lifestyle


Jian Jun maintains the professional, composed style of a corporate executive. Her attire is consistently formal and high-quality, favoring tailored business suits. Her aesthetic reflects stability and immense intellectual authority, typical of a leader in the specialized medical beauty sector.

Residing in Beijing, China, her luxury is the immense security and financial reward derived from her multi-billion dollar fortune. Her life is dedicated to scientific scale, technological innovation, and the long-term, stable growth of the aesthetic medicine market.

Advertisement

Quotes and Philosophy


No publicly available quotes.

Fun Facts & Trivia


  • She is the Chairwoman of Imeik Technology Development (aesthetic medicine products).
  • Her company's stock surged over 500 percent after its 2020 IPO.
  • She holds an MBA from Tsinghua University.
  • Her company is famous for its Hearty filler that treats neck wrinkles.
  • She became interested in injection treatments while working abroad (beauty lunch nickname).
  • She was ranked the 34th richest self-made woman in the world in 2025.
  • Her wealth is tied to the successful industrialization of non-surgical cosmetic procedures.

Advertisement

More Profiles


Antti Herlin

+0.21% | +$9.50M

Kentaro Ogawa

+0.1% | +$4.05M

You May Like


Sources & References


This profile is compiled from verified biographical and financial records:

  • Wealth Data: Real-time tracking and historical data from Forbes Billionaires and the Bloomberg Billionaires Index.
  • Biographical Records: Educational and career history sourced from Reuters, The Wall Street Journal, and official university alumni directories.
  • Regulatory Filings: Shareholder and executive disclosures from stock exchange databases, including HKEX, SSE, SZSE, and SEC EDGAR.
  • Corporate History: Primary data from annual company reports, founding charters, and verified press announcements.

All information is cross-referenced with public sources for accuracy; some narrative sections are AI-assisted summaries.

If you find any inaccuracies, please report them to admin@redcarpetlife.in

Sponsored Content